Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Predicting Treatment Response to Antitumor Necrosis Factor Agents: An Update From ACR 2008
Link ID 11444
Title Predicting Treatment Response to Antitumor Necrosis Factor Agents: An Update From ACR 2008
Url http://www.medscape.com/viewarticle/585027?src=rss
Description Review the latest data from the ACR 2008 meeting on genomic markers, biomarkers, gene expression markers, and clinical features that may help direct rheumatoid arthritis therapy.
Medscape Rheumatology
Category Articles > Pharmacists
Keywords
Date Dec 11, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Intravenous Therapy for Hypertensive Emergencies, Part
  Tailoring drug selection according to individual patient characteristics can optimize the management and potential outcomes of patients with hypertensive emergency. American Journal of Health-System Pharmacy
Category:   Articles > Pharmacists


2. Funding Bill May Address Drug Shortages: AidesFunding Bill May Address Drug Shortages: Aides
  Legislation aimed at relieving shortages of crucial drugs to treat cancer and other illnesses may get momentum next week when lawmakers decide whether to attach it to a must-pass funding bill for the FDA. Reuters Health Information
Category:   Articles > Pharmacists


3. First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
  The FDA has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths. Medscape Medical News
Category:   Articles > Pharmacists


4. Predicting Treatment Response to Antitumor Necrosis Factor Agents: An Update From ACR 2008
  Review the latest data from the ACR 2008 meeting on genomic markers, biomarkers, gene expression markers, and clinical features that may help direct rheumatoid arthritis therapy.
Medscape Rheumatology
Category:   Articles > Pharmacists


5. Bupropion Plus Naltrexone for Weight Loss?
  The combination of bupropion and naltrexone is being studied for possible weight-loss effects through its synergistic action on appetite signaling and the mesolimbic reward system. Journal Watch
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS